YSYanina Sguassero

Yanina Sguassero

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yanina Sguassero has a total of 95 co-authors. Here are the top co-authors by number of shared publications:

  • Mercedes de Onis

    World Health Organization; Department of Nutrition for Health and Development; 20 Avenue Appia Geneva Switzerland 1211 Geneva 27

    4 shared publications
  • Alicia Orellano

    National University of Rosario; Cafferata 1614 Rosario 2000 Santa Fe Argentina

    3 shared publications
  • Guillermo Carroli

    Centro Rosarino de Estudios Perinatales; Moreno 878 Rosario Argentina S2000DKR

    3 shared publications
  • Agustín Ciapponi

    Servicio de Medicina Familiar y Comunitaria, Hospital Italiano de Buenos Aires; Centro Cochrane Argentina, Instituto de Efectividad Clínica y Sanitaria

    2 shared publications
  • Benjamin Johnson

    Yale Centre for Analytic Science, Yale University School of Public Health, New Haven, CT, USA

    2 shared publications
  • Berenise Carroli

    2 shared publications

Latest Publications

  • Open Access

    Optimizing the use of cesarean section in Argentina: design and methodology of a formative research for the development of interventions

    by Silvina Ramos, Mariana Romero, Carla Perrotta, Yanina Sguassero, Cecilia Straw, Celina Gialdini, Natalia Righetti, Ana P. Betran

    Background: While cesarean section is an essential life-saving strategy for women and newborns, its current overuse constitutes a global problem. The aim of this formative research is to collect information from hospitals, health professionals and women regarding the use of cesarean section in Argentina. This article describes the methodology of the study, the characteristics of the hospitals and the profile of the participants. Methods: This formative research is a mixed-method study that will be conducted in seven provinces of Argentina. The eligibility criteria for the hospitals are (a) use of the Perinatal Information System, (b) cesarean section rate higher than 27% in 2016, (c) ≥ 1000 deliveries per year. Quantitative and qualitative research techniques will be used for data collection and analysis. The main inquiry points are the determining factors for the use of cesarean section, the potential interventions to optimize the use of cesarean section and, in the case of women, their preferred type of delivery. Discussion: It is expected that the findings will provide a situation diagnosis to help a context-sensitive implementation of the interventions recommended by the World Health Organization to optimize cesarean section use. Trial registration IS002316 Plain English Summary: Cesarean section is an essential medical tool for mothers and their children, but nowadays its overuse is a problem worldwide. Our purpose is to get information from hospitals, health professionals and women about how cesarean section is used in Argentina. In this protocol we describe how we will carry out the study and the characteristics of the hospitals and participants. We will implement this study in seven provinces of Argentina, in hospitals that have more than 1,000 births each year, had a cesarean section rate higher than 27% in 2016 and use the Perinatal Information System. We will gather information using forms, surveys and interviews. We want to identify the factors that decide the use of a cesarean section, the potential interventions that can improve the use of cesarean section and, in the case of women, the type of delivery they prefer. We expect that this study will give us a diagnosis of how cesarean section is used in Argentina, and that this will help to apply the interventions that the World Health Organization recommends to optimize the use of cesarean section in our specific context.


  • Validation of the International Guide for Monitoring Child Development demonstrates good sensitivity and specificity in four diverse countries

    by Ilgi Ozturk Ertem, Vibha Krishnamurthy, Mphelekedzeni C. Mulaudzi, Yanina Sguassero, Burcu Bilik, Roopa Srinivasan, Hakan Balta, Ozlem Gulumser, Geliang Gan, Lisa Calvocoressi, et al.

    Aim: It is of critical importance to have internationally constructed tools to address early childhood development. The aim of this second phase of a two‐phase study was to examine the sensitivity and specificity of the Guide for Monitoring Child Development (GMCD) in identifying developmental delay in four diverse countries.Methods: The first phase of this 2011–2015 back‐to‐back study included 4949 children up to 42 months of age from primary healthcare centres in Argentina, India, South Africa and Turkey. Distribution curves were generated to show the ages when the children attainedGMCDmilestones and those that could be used across sexes and countries were placed in age ranges corresponding to the 85th and 97th percentile point estimates. Phase two examined a separately recruited sample of children in those countries to determine sensitivity and specificity of theGMCD.Results: The validation phase of the 85 milestones in theGMCDidentified delayed development in 30% of the 1731 children in the four countries. The sensitivity and specificity ranged from 0.71–0.94 and 0.69–0.82, respectively, for the total sample and the different age groups.Conclusion: TheGMCDstandardised in four diverse countries has appropriate accuracy for identification of children with developmental delay.


  • Open Access

    Course of serological tests in treated subjects with chronic Trypanosoma cruzi infection: A systematic review and meta-analysis of individual participant data

    by Yanina Sguassero, Karen N. Roberts, Guillermina B. Harvey, Daniel Comandé, Agustín Ciapponi, Cristina B. Cuesta, Camila Aguiar, Ana M. de Castro, Emmaría Danesi, Ana L. de Andrade, et al.


  • Community-acquired methicillin-resistant Staphylococcus aureus infections: 10-years’ experience in a children’s hospital in the city of Rosario, Argentina

    by Gabriela Ensinck, Adriana Ernst, Gustavo Lazarte, Antonela Romagnoli, Yanina Sguassero, Nanci Miguez, Santiago Lopez Papucci, Alicia Aletti, Ana Chiossone, Fernanda Pigozzi, et al.

    Introduction: Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections are a common reason for consultation in pediatrics. Most of them present as skin and soft tissue infections; however, invasive infections have increased during the last decade. Objectives: The main objective was to describe the clinical-epidemiological characteristics of CA-MRSA infections. The secondary objective was to compare prevalence, clinical presentation and antibiotic susceptibility with a pre-study period (1/2004-12/2007). Material and methods: This is a descriptive, prospective, cross-sectional study. Inclusion criteria: children who have been diagnosed with CA-MRSA infection and admitted to Hospital de Ninos de Rosario between January 2008 and December 2014. Exclusion criteria: recent hospitalization, previous antibiotic treatment or surgery, comorbidities or immune compromise. Results: Out of 728 cases of children with Staphylococcus aureus infections, 529 (73%) were due to CA-MRSA. The incidence rate of CA-MRSA infections varied from 12.2/10 000 hospital discharges in 2004 to 145/10 000 in 2014: 75% (391) were skin and soft tissue infections; 8% (43) were osteoarticular infections; 6% (30), pleuropulmonary infections; 5% (24), sepsis. There was an increase in the number of invasive infections in the second period, with no statistical significance (OR=0.895; CI: 0.52-1.53). Gentamicin, clindamycin and erythromycin resistance remained stable throughout both periods. Conclusion: CA-MRSA infections were increasingly more frequent, mainly skin and soft tissue infections. An increase was observed in the number of invasive infections, with no statistical significance. Antibiotic resistance remained stable.


  • Open Access

    Similarities and differences in child development from birth to age 3 years by sex and across four countries: a cross-sectional, observational study

    by Ilgi Ozturk Ertem, Vibha Krishnamurthy, Mphelekedzeni C Mulaudzi, Yanina Sguassero, Hakan Balta, Ozlem Gulumser, Burcu Bilik, Roopa Srinivasan, Benjamin Johnson, Geliang Gan, et al.


  • The perspective of primary health care pediatricians regarding childhood anemia and iron supplementation

    by Yanina Sguassero, Marcia M Guerrero, Mariana Romero

    Iron deficiency anemia is common in low- and middle-income countries. According to the evidence, the impact of ferrous sulfate supplementation in the pediatric population is low. Our objective was to analyze the perspective of pediatricians regarding anemia and iron supplementation. Qualitative, exploratory study. Semi-structured interviews were conducted with primary health care pediatricians from Rosario. Three core inquiry concepts were included: importance of this problem, clinical practice, and representations about iron supplementation. The analysis consisted in the systematization of the information collected by transcribing the recorded interviews and notes. A total of 32 interviews were conducted. All interviewees considered anemia was a relevant problem. At present, anemia is associated with a poor-quality diet. Based on the findings, pediatric practice follows national standards. There is consensus that low adherence is a barrier for the clinical management of iron deficiency anemia. Pediatricians described concepts that are potentially beneficial for the local setting, including workshops on anemia and free provision of more flavorful iron supplements. Iron deficiency anemia was considered a severe problem. In the primary health care setting, outstanding interventions included workshops and access to more flavorful iron supplements.


  • Open Access

    Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies

    by Yanina Sguassero, Cristina B Cuesta, Karen N Roberts, Elizabeth Hicks, Daniel Comandé, Agustín Ciapponi, Sergio Sosa-Estani

    Chagas disease is caused by the flagellate protozoan Trypanosoma cruzi (T. cruzi). It is endemic in Latin American countries outside the Caribbean. The current criterion for cure in the chronic phase of the disease is the negativization of at least two serological tests such as enzyme-linked immunosorbent assay (ELISA), indirect immunofluorescence assay (IIF) and indirect hemagglutination assay (IHA). The serological evolution of treated subjects with chronic T. cruzi infection is variable. Treatment failure is indicated by a positive parasitological and/or molecular test (persistence of parasitemia). To summarize the pattern of response to treatment of parasitological, molecular and serological tests performed during the follow-up of subjects with chronic T. cruzi infection. Electronic searches in relevant databases and screening of citations of potentially eligible articles were accomplished. Organizations focusing on neglected infectious diseases were asked for help in identifying relevant studies. Included studies were randomized controlled trials (RCTs), quasi-RCTs, and cohort studies involving adults and children with chronic infection who received trypanocidal treatment (benznidazole or nifurtimox) and were followed over time. The assessment of risk of bias was performed separately for each study design. The Cochrane Collaboration’s tool and the guidelines developed by Hayden et al. were used. Two reviewers extracted all data independently. A third review author was consulted in case of discordant opinion. Additional analyses were defined in ad-hoc basis. Scatter plots for percentage of positive parasitological and molecular tests and for negative serological tests were developed by using the lowess curve technique. Heterogeneity was measured by I2. The protocol was registered in PROSPERO, an international prospective register of systematic review protocols (Registration Number CRD42012002162). Out of 2,136 citations screened, 54 studies (six RCTs and 48 cohort studies) were included. The smoothed curves for positive xenodiagnosis and positive polymerase chain reaction (PCR) were characterized by a sharp decrease at twelve month posttreatment. Afterwards, they reached 10–20% and 40% for xenodiagnosis and PCR, respectively. The smoothed curves for negative conventional serological tests increased up to 10% after 48 months of treatment. In the long-term, the rate of negativization was between 20% and 45%. The main sources of bias identified across cohort studies were the lack of control for confounding and attrition bias. In general, RCTs were judged as low risk of bias in all domains. The level of heterogeneity across included studies was moderate to high. Additional analysis were incomplete because of the limited availability of data. In this regard, the country of origin of study participants might affect the results of parasitological and molecular tests, while the level of risk of bias might affect serological outcomes. Subgroup analysis suggested that seronegativization occurs earlier in children compared to adults. We acknowledge that there is a dynamic pattern of response based on parasitological, molecular and serological tests in subjects chronically infected with T. cruzi after treatment. Our findings suggest a trypanocidal effect in the long-term follow-up. Further research is needed to explore potential sources of heterogeneity and to conduct reliable subgroup analysis.


  • Community-based supplementary feeding for promoting the growth of children under five years of age in low and middle income countries

    by Yanina Sguassero, Mercedes de Onis, Ana María Bonotti, Guillermo Carroli

    Supplementary feeding is defined as the provision of extra food to children or families beyond the normal ration of their home diets. The impact of food supplementation on child growth merits careful evaluation in view of the reliance of many states and non‐governmental organisations on this intervention to improve child health in low and middle income countries (LMIC). This is an update of a Cochrane review first published in 2005. To evaluate the effectiveness of community‐based supplementary feeding for promoting the physical growth of children under five years of age in LMIC. For this updated review we searched the following databases on 31 January 2011: CENTRAL (The Cochrane Library), MEDLINE (1948 to January week 3, 2011), EMBASE (1980 to week 3, 2011), CINAHL (1937 to 27 January 2011), LILACS (all years), WorldCat for dissertations and theses (all years) and ClinicalTrials.gov (all years). Randomised controlled trials (RCTs) evaluating supplementary feeding in comparison to a control group (no intervention or a placebo such as food with a very low number of nutrients and calories) in children from birth to five years of age in LMIC. Two review authors independently extracted and analysed the data. We included eight RCTs (n = 1243 children) that were at relatively high risk of bias. We found high levels of clinical heterogeneity in the participants, interventions and outcome measures across studies. Nevertheless, in order to quantify pooled effects of supplementary feeding, we decided to combine studies according to prespecified characteristics. These were the children's age (younger or older than 24 months), their nutritional status at baseline (stunted or wasted, or not stunted or wasted) and the duration of the intervention (less or more than 12 months). A statistically significant difference of effect was only found for length during the intervention in children aged less than 12 months (two studies; 795 children; mean difference 0.19 cm; 95% confidence interval (CI) 0.07 to 0.31). Based on the summary statistic calculated for each study, the mean difference (MD) between intervention and control groups ranged from 0.48 cm (95% CI 0.07 to 0.89) to 1.3 cm (95% CI 0.03 to 2.57) after 3 and 12 months of intervention, respectively. Data on potential adverse effects were lacking. The scarcity of available studies and their heterogeneity makes it difficult to reach any firm conclusions. The review findings suggest supplementary feeding has a negligible impact on child growth; however, the pooled results should be interpreted with great caution because the studies included in the review are clinically diverse. Future studies should address issues of research design, including sample size calculation, to detect meaningful clinical effects and adequate intervention allocation concealment. In the meantime, families and children in need should be provided appropriate feeding, health care and sanitation without waiting for new RCTs to establish a research basis for feeding children. 以社區為基礎的食物補給增進發展中國家幼童的生長 食物補給的定義為,對貧窮的孩童或家庭,在其家庭正常的飲食量之外,再給予額外的食物。既然許多國家和非政府組織 (NGOs) 都藉助此方法來改善發展中國家的孩童健康,食物補充對於孩童的成長影響,值得仔細的評估。 評估以社區為基礎的食物補給,對增進發展中國家學齡前孩童生長的效果。 搜尋下列資料庫: CENTRAL 2005年 (Issue 2) ,MEDLINE 1966年至2005年,EMBASE 1980年至2005年,CINAHL 1982年 至2005年,LILACS 1982年至2005年,Social Science Citation Index 1956年至2005年,和Dissertation Abstracts International (1960年代晚期至2005年) 。 評估發展中國家0至5歲孩童之食物補給的隨機對照試驗。 2位作者分別擷取和分析資料。 在這篇回顧中,共有4篇試驗符合選擇標準。因為被納入的試驗臨床上的異質性,並不適合進行統合分析。我們把這些試驗分成2類: 1. 基準點時沒有正式營養不良程度評估的試驗,2. 基準點時有評估營養狀況。1. 一組1991年在印尼做的隨機對照試驗 (共有20個日間照護中心,個案數113) ,發現對於年齡相對體重和年齡相對身高部份的z分數,在介入3個月之後,治療組與控制組比較起來沒有益處。在另一個於瓜地馬拉進行的試驗,包括了4個村莊做為分析的基準單位 (實際的樣本大小並未提供) 。3歲孩童的身高,基於村莊大小和補給的種類,做 ‘之前與之後的比較’ 。根據這個分析,淨改變的差異,在大型的村莊是2.55公分,在小型的村莊是2.35公分。這些差異的平均值為2.45加減0.10公分 (平均加減標準差) 。 一個在牙買加做的試驗 (樣本數65個孩童) ,顯示在12個月之後,接受食物補給的組別相較控制組,在身高上有正向的效果 (WMD 1.3 (0.03到2.57)) 。另一個印尼的試驗 (樣本數75名孩童) 顯示,在12個月的補給後,在成長方面並沒有益處。 依據試驗得到少量樣本並沒辦法做出食物補給對於學齡前孩童的成長效果確切的結論。在將來的試驗中,研究設計中關於盲法 (binding) 和樣本大小之計算要加強。 本摘要由成功大學附設醫院紀美宏翻譯。 此翻譯計畫由臺灣國家衛生研究院 (National Health Research Institutes, Taiwan) 統籌。 在發展中國家,營養不良是造成孩童發病和死亡的主要基本原因。其平常家庭食用量提供貧窮的孩童或家庭額外的食物,是針對目標族群在營養方面的介入方式。我們在這篇回顧中,找到四個符合選擇標準的隨機對照試驗。根據回顧目前已發表的證據,食物補給對學齡前孩童生長的好處並無有力的結論支持。而相對小型的試驗,顯示在這個領域中,需要更進一步的研究。 L'alimentation supplémentaire communautaire pour promouvoir la croissance des enfants de moins de cinq ans dans les pays à revenu faible et intermédiaire Une alimentation supplémentaire est définie comme l'apport d'un supplément de nourriture pour les enfants et les familles au‐delà de la ration normale dans leurs propres régimes alimentaires. L'impact d'une alimentation supplémentaire sur la croissance des enfants mérite une évaluation toute particulière étant donné l'appui de nombreux états et organisations non gouvernementales vis à vis de cette intervention pour améliorer la santé des enfants dans les pays à revenu faible à intermédiaire (PRFI). Ceci est une mise à jour d’une revue Cochrane publiée pour la première fois en 2005. Évaluer l'efficacité de l'alimentation supplémentaire communautaire pour promouvoir la croissance physique des enfants de moins de cinq ans dans les PRFI. Pour cette mise à jour, nous avons effectué une recherche dans les bases de donnée suivantes le 31 janvier 2011 : CENTRAL (The Cochrane Library), MEDLINE (de 1948 à la 3ème semaine de janvier 2011), EMBASE (de 1980 à la 3ème semaine 2011), CINAHL (de 1937 au 27 janvier 2011), LILACS (toutes les années), WorldCat for dissertations and theses (toutes les années) et ClinicalTrials.gov (toutes les années). Les essais contrôlés randomisés (ECR) évaluant l'alimentation supplémentaire par rapport à un groupe témoin (aucune intervention ou un placébo comme une alimentation avec une très faible quantité de nutriments et de calories), chez les enfants de la naissance à cinq ans dans les PRFI. Deux auteurs ont extrait et analysé les données, de façon indépendante. Nous avons inclus huit ECR (n = 1 243 enfants) qui avaient un risque de biais relativement élevé. Nous avons trouvé des niveaux élevés d'hétérogénéité clinique chez les participants, dans les interventions et les mesures des résultats entre les études. Pour autant, de manière à quantifier les effets groupés d'une alimentation supplémentaire, nous avons décidé de combiner les études en fonction de caractéristiques pré‐spécifiées. Il y avait l'âge de l'enfant (moins ou plus de 24 mois), leur statut nutritionnel de base (retard de croissance ou insuffisance pondérale, ou pas de retard de croissance ou d'insuffisance pondérale) et la durée de l'intervention (moins ou plus de 12 mois). Une différence d'effet significative en termes statistiques a uniquement été découverte pour la durée au cours de l'intervention chez les enfants de moins de 12 mois (deux études ; 795 enfants ; différence moyenne 0,19 cm ; IC à 95 % 0,07 à 0,31). En se basant sur le résumé statistique calculé pour chaque étude, la différence moyenne (DM) entre les groupes avec intervention et les groupes témoins allait de 0,48 cm (IC à 95 % 0,07 à 0,89) à 1,3 cm (IC à 95 % 0,03 à 2,57) après respectivement 3 et 12 mois d'intervention. Il manquait les données sur les effets indésirables potentiels. La rareté des études disponibles et leur hétérogénéité rend difficile l'établissement de conclusions fermes. Les découvertes de la revue suggèrent qu'une alimentation supplémentaire a un impact négligeable sur la croissance de l'enfant ; pour autant, les résultats groupés devront être interprétés avec précaution parce que les études incluses dans la revue étaient cliniquement différentes. Des études ultérieures devraient aborder les thèmes traitant de la conception de la recherche, y compris le calcul de la taille de l'échantillon, afin de détecter les effets cliniques importants et l'assignation secrète adéquate de l'intervention. En même temps, les familles et les enfants dans le besoin devraient recevoir une alimentation appropriée, des soins de santé et d'hygiène sans devoir attendre que des nouveaux ECR établissent une base de recherche pour nourrir les enfants. 以社区为基础的食物补充促进发展中国家儿童的生长 食物补充的定义为,在家庭正常的饮食量之外,对儿童或家庭再给予额外的食物。鉴于许多国家和非政府组织都相信该方法可改善发展中国家的儿童健康,因此需要加以认真评估。 评价以社区为基础的食物补充对促进发展中国家学龄前儿童体格生长的效果。 检索了CENTRAL(2005,第二期),MEDLINE(1966∼2005),EMBASE(1980∼2005),CINAHL(1982∼2005),LILACS(1982∼2005),Social Science Citation Index (1956∼2005)和Dissertation Abstracts International(1960年代后期∼2005年)等数据库。 评估发展中国家0∼5岁儿童食物补充效果的随机对照试验。 由两位评价者独立地提取并分析数据。 本系统评价中,共有4个试验符合纳入标准。被纳入的试验具有临床上的异质性,因此不适合进行Meta‐分析。我们把这些试验分成两类: a) 缺乏正式评估营养不良状况的基线数据,b) 具有正式评估营养不良状况的基线数据。 a) 1991年在印尼开展的一个整群随机对照试验(共有20个日间照护中心,113名儿童) 发现,干预3个月后,干预组年龄别体重和年龄别身高的z值并不比对照组更好。一个在危地马拉进行的研究,根据村庄大小和补充的种类,对3岁儿童的身高进行了“干预前后的比较”(确切的样本量大小并未提供)。根据分析发现,身高净值的改变,在大型村庄为2.55 cm,而在小型村庄为2.35 cm,这些差异的平均值为2.45±0.10 cm(均数±标准差)。 b) 一个在牙买加进行的试验 (包含65名儿童)报道: 在干预12个月后,接受食物补充组与对照组相比,儿童的身高增长有明显效果(WMD: 1.3,0.03∼2.57)。一个来自印尼的试验(包含75名儿童)发现,对儿童进行12个月的食物补充后,其生长方面并未获益。 基于现有试验数量较少,食物补充对于学龄前儿童的生长是否有效尚不能得出确切结论。在将来的研究中,需要解决一些研究的设计问题,如盲法和样本量估计。


  • Commentaries on ‘Hand washing for preventing diarrhoea’, with a response from the review authors

    by Diana Pinto‐Masis, Yanina Sguassero, Regina I. Ejemot, John E. Ehiri, Martin M. Meremikwu, Julia A. Critchley

    These are commentaries on a Cochrane review, published in this issue of EBCH, first published as: Ejemot RI, Ehiri JE, Meremikwu MM, Critchley JA. Hand washing for preventing diarrhoea. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD004265. DOI: 10.1002/14651858.CD004265.pub2.Further information for this Cochrane review is available in this issue of EBCH in the accompanying Summary article. Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. The Cochrane Collaboration